Efficacy and Safety of Acupuncture for Dizziness and Vertigo in Emergency Department: a Clinical Control Trial

Dizziness Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02358239
• Other study ID #: 120403
• Status: Completed
• Phase: N/A
• First received: January 28, 2015
• Last updated: February 3, 2015
• Start date: February 2013
• Est. completion date: February 2014

Study information

• Verified date: February 2015
• Source: Changhua Christian Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Ministry of Health and Welfare
• Study type: Interventional

Clinical Trial Summary

Dizziness and vertigo account for roughly 4% of chief symptoms in the emergency department (ED). Pharmacological therapy is often solicited for these symptoms, such as vestibular suppressants, anti-emetics and benzodiazepines. However, every medication is accompanied with unavoidable side-effects. To the best of the investigators knowledge, no papers surveyed assess the feasibility of applying acupuncture as an emergent intervention means to the treatment of dizziness and vertigo. The investigators study targeted on filling in this gap by performing a clinical control trial to evaluate the efficacy and safety of traditional Chinese medicine - acupuncture - in treating patients with dizziness and vertigo in ED.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: February 2014
• Est. primary completion date: December 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 90 Years

Eligibility

Inclusion Criteria:

• Visit emergency department and stay in observation unit.

• Consult otolaryngologist and neurologist to rule in dizziness and giddiness, auditory vertigo, vertebrobasilar artery syndrome, and peripheral vestibular disorders - Ménière's disease, benign paroxymal peripheral vertigo, and vestibular neuritis.

Exclusion Criteria:

1. Serious comorbid conditions (for example, life-threatening condition or progressive central disorder).

2. Patients who cannot communicate reliably with the investigator or who are not likely to obey the instructions of the trial.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Dizziness
• Vertigo

Intervention

Procedure:
• acupuncture
Experiment group received acupuncture at Zusanli (ST36) and Neiguan (PC6) acupuncture points

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Po-Chi Hsu

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analog Scale (VAS) of dizziness		after the first 30 minutes after acupuncture	Yes